Pharma giant takes $95 million stake in France’s Valneva
Pfizer has purchased an 8.1% stake in Valneva. The companies are collaborating on a Lyme disease vaccine. PFE shares recently broke through long-term support. With markets closed for the Juneteenth holiday on Monday, Pfizer (PFE) announced a $95.2 million stake in French vaccine maker Valneva, according to Reuters. The investment gives Pfizer an 8.1% position … Read more